Back to Aberdeen Group plc Aberdeen Group plc

CVSCVS
30 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in CVS HEALTH CORP

Yes. Aberdeen Group holds 1,739,609 shares of CVS (CVS Health), worth $180M, as of its Q2 2026 13F filing. It increased the position by 125,103 shares (+7.8%) from Q1 2026. Aberdeen Group has held CVS in every 13F on record since Q1 2019, 30 quarterly filings. CVS is 0.3% of Aberdeen Group's reported 13F portfolio.

Current Value

$180M

Current Shares

1.7M

Total Value Change

+$122.7M

Total Shares Change

+678,457

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+7.8%
$180M0.3%$102.81
39
2026-Q1
Decreased
1.6M
-1.9%
$116M0.2%$70.76
0
2025-Q4
Decreased
1.6M
-2.7%
$130.5M0.2%$77.55
0
2025-Q3
Increased
1.7M
+43.5%
$127.8M0.2%$73.07
49
2025-Q2
Increased
1.2M
+3.0%
$81.3M0.1%$66.14
37
2025-Q1
Increased
1.1M
+52.4%
$77.3M0.2%$64.29
50
2024-Q4
Decreased
750,111
-6.7%
$33.2M0.1%$42.07
0
2024-Q3
Decreased
803,926
-43.9%
$50.2M0.1%$58.27
0
2024-Q2
Decreased
1.4M
-11.1%
$84.7M0.2%$54.12
0
2024-Q1
Decreased
1.6M
-17.2%
$128.7M0.3%$72.39
0
2023-Q4
Decreased
1.9M
-34.6%
$153.8M0.3%$71.02
0
2023-Q3
Decreased
3M
-2.6%
$208.1M0.5%$62.27
0
2023-Q2
Increased
3.1M
+1.7%
$211.4M0.5%$61.15
37
2023-Q1
Increased
3M
+0.1%
$223.5M0.6%$65.20
43
2022-Q4
Increased
3M
+1.0%
$280M0.8%$81.20
44
2022-Q3
Increased
3M
+230.2%
$283.8M0.8%$82.60
70
2022-Q2
Increased
901,148
+54.1%
$83.7M0.3%$79.79
50
2022-Q1
Decreased
584,810
-20.2%
$59.9M0.2%$86.70
0
2021-Q4
Decreased
732,560
-28.8%
$75.6M0.2%$87.90
0
2021-Q3
Decreased
1M
-18.5%
$88.2M0.2%$71.89
0
2021-Q2
Increased
1.3M
+43.0%
$105.3M0.2%$70.26
48
2021-Q1
Increased
882,624
+3.8%
$66.4M0.2%$62.94
37
2020-Q4
Increased
850,436
+2.1%
$58.1M0.1%$56.76
36
2020-Q3
Decreased
832,826
-5.6%
$48.6M0.1%$48.12
0
2020-Q2
Increased
882,463
+1.2%
$57.3M0.2%$53.12
36
2020-Q1
Increased
871,657
+6.6%
$51.8M0.2%$48.11
37
2019-Q4
Decreased
817,679
-5.7%
$60.7M0.1%$59.84
0
2019-Q3
Increased
866,825
+0.8%
$54.7M0.1%$50.42
35
2019-Q2
Decreased
860,411
-18.9%
$46.9M0.1%$43.17
0
2019-Q1
First report
1.1M
-
$57.2M0.1%$42.32
0

Other major holders of CVS: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used